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Analyte isobaric interferences can limit the development of a comprehensive analytical 21 
method for the quantitative liquid chromatography-tandem mass spectrometry profiling of an 22 
important cohort of veterinary drugs. In this work, a selective chromatographic separation 23 
was developed for the analysis of 32 β-lactam antibiotic residues (12 penicillins, 14 24 
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cephalosporins, five carbapenems and faropenem) in milk samples. A range of analytical 25 
columns with different stationary phases and mobile phases were evaluated for retention and 26 
separation of the β-lactam compounds. Results showed that, among the columns tested, only 27 
phenyl-hexyl could adequately separate ampicillin from cephalexin and amoxicillin from 28 
cefadroxil, which had shown isobaric interferences on a number of stationary phases. 29 
Chromatography was performed using a water/acetonitrile binary gradient with formic acid 30 
and ammonium acetate. The β-lactam residues were extracted from the milk samples using a 31 
water:acetonitrile solution and purified by C18 dispersive solid-phase extraction (d-SPE) 32 
clean-up, followed by concentration under nitrogen and ultra-high performance liquid 33 
chromatography-tandem mass spectrometry (UHPLC-MS/MS) determination. Analytes were 34 
monitored in positive electrospray ionization mode (ESI(+)). Possible interfering matrix 35 
effects were overcome by using 13 internal standards. The method was fully validated 36 
according to 2002/657/EC guidelines, showing satisfactory performance characteristics. 37 
Under within-laboratory reproducibility conditions, trueness and precision ranged from 91% 38 
to 130% and from 1.4% to 38.6%, respectively. Decision limits (CCα) were in the range 2.1-39 
133 µg kg-1. Limits of detection (LODs) and quantitation (LOQs) ranged between 0.0090 and 40 
1.5 µg kg-1 and from 0.030 to 5.0 µg kg-1, respectively.  41 
 42 
 43 
1. Introduction 44 
β-Lactam antibiotics are widely used in lactating dairy cattle for the treatment of infections. 45 
Residues of antibiotics may be found in milk following improper administration or if 46 
withdrawal periods are not respected, and may result in adverse effects on human health and 47 
development of antibiotic-resistant bacteria. Moreover, these residues can interfere with 48 
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cheesemaking process by inhibiting the growth of starter cultures, causing technological 49 
problems in dairy industry [1]. A review comparing different researches on antibiotic 50 
residues in milk in published literatures found the β-lactams to be the most detected 51 
antibiotics, followed by  tetracyclines, fluoroquinolones, sulfonamides and aminoglycosides 52 
[2]. 53 
Penicillins and cephalosporins are the most important β-lactams used in both human and 54 
veterinary medicine, while carbapenems play a fundamental role and are approved in human 55 
medicine only. In order to minimise exposure and protect public health, Maximum Residue 56 
Limits (MRLs) have been established by Commission Regulation 2010/37/EU for eight 57 
cephalosporins and seven penicillins in milk (Table 1), some of which are as low as 4 µg kg-1 58 
[3]. As a consequence, analytical detection methods are required to be very sensitive. These 59 
methods should include a number of metabolites, as Commission Regulation 2010/37/EU 60 
specifies that the marker residue for cephapirin should be the sum of the parent drug and its 61 
main metabolite, namely desacetyl cephapirin (DAC), while results for ceftiofur should be 62 
the sum of all residues retaining the β-lactam structure, expressed as desfuroylceftiofur.  63 
The majority of β-lactam analysis of milk samples is carried out at dairy processing plants by 64 
using low cost inhibition assays that allow rapid analysis of large numbers of samples, while 65 
more sensitive laboratory-based methods have been developed using microbiological, 66 
biosensor and immunochemical techniques [4]. However, the need for confirmation and 67 
accurate quantitation has led to the application of chromatographic-based methods coupled to 68 
detectors such as UV, fluorescence or mass spectrometry. Liquid chromatography and 69 
tandem mass spectrometry (LC-MS/MS) are often used because of the requirement to analyse 70 
a wide range of compounds simultaneously in a relatively short analytical run time. Mass 71 
spectrometry has also become the technique of choice because of its selectivity, which is 72 
particularly important in the case of β-lactams due to the similarity in their molecular 73 
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structures [5]. However, chromatographic selectivity is also required when co-eluting 74 
compounds with similar masses show very similar fragmentation. Reversed-phase 75 
chromatography on C18 columns is the most common analytical tool in the analysis of β-76 
lactams [6, 7], although retention of polar compounds and selectivity of structurally similar 77 
molecules can be a challenge and thus require alternative phases such as phenyl and biphenyl, 78 
mixed-mode or hydrophilic interaction liquid chromatography (HILIC) [8, 9]. 79 
The aim of this work was to develop a sensitive and accurate UHPLC-MS/MS method to 80 
measure 32 β-lactam residues in milk. The method consists of all the regulated β-lactams [3], 81 
including two main drugs, namely cephapirin and ceftiofur, as well as their major 82 
metabolites, and a number of unique non-regulated compounds at target levels (TLs) that 83 
were established based on the sensitivity of the method (Table 1). Among these non-MRL 84 
compounds, the carbapenems, faropenem, and a number of penicillins and cephalosporins 85 
were selected because of their importance in human medicine. The analysis of these drugs in 86 
foodstuffs can, indeed, allow to determine whether an illegal or off-label use was employed, 87 
therefore preventing the possibility of veterinary residues reaching consumers through the 88 
food chain. This is extremely important due to the rising resistance to cephalosporins and the 89 
emergence of carbapenem resistance [10]. As a consequence, analytical methods able to 90 
determine as many β-lactams as possible, at low levels, are of importance, and the outlined 91 
study focused on a large number of drugs that are normally not included in the vast majority 92 
of published papers reported in the literature. Another particularly important objective was 93 
the evaluation of novel chromatographic stationary phases to improve the separation of 94 
structurally similar β-lactams, namely amoxicillin from cefadroxil and ampicillin from 95 
cephalexin. These compounds had shown isobaric interferences following application of 96 
conventional columns such as C18 [11], which could not give satisfactory separation and 97 
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could lead to ambiguities in quantitation or confirmation of the residues when applied to the 98 
analysis of milk. 99 
 100 
 101 
2. Materials and Methods 102 
 103 
2.1. Chemicals, materials and apparatus 104 
Acetonitrile (MeCN) and methanol (MeOH) were HPLC grade and supplied by Romil Ltd 105 
(Cambridge, UK). Ultra-pure water (18.2 MΩ cm-1) was generated in-house using a Millipore 106 
water purification system (Cork, Ireland). Dimethyl sulfoxide (DMSO), formic acid 107 
(HCOOH) 98-100%, ammonium formate and ammonium acetate were supplied by Sigma-108 
Aldrich (Dublin, Ireland). Glacial acetic acid (CH3COOH) 100% was purchased from Merck 109 
(Darmstadt, Germany). 110 
Polypropylene tubes (15 mL and 50 mL) with screw caps were obtained from Sarstedt Ltd 111 
(Wexford, Ireland). QuEChERS 500 mg C18 (endcapped) 50 mL centrifuge tubes were 112 
purchased from United Chemical Technologies Ltd (Wexford, Ireland). Syringeless mini-113 
uniprep PTFE filter devices were sourced from Whatman plc (Maidstone, UK). A ME36S 114 
microbalance and an A200S digital electronic analytical balance (both from Sartorius, 115 
Dublin, Ireland) were used for standard preparation. A Talboys Advanced Multi Tube 116 
Vortexer (Troemner, NJ, USA), a Rotanta 460R refrigerated centrifuge (Hettich, 117 
Kirchlengern, Germany) and a TurboVap LV evaporator (Biotage, Uppsala, Sweeden) were 118 
employed for sample preparation. 119 
Ampicillin trihydrate, cloxacillin sodium salt monohydrate, dicloxacillin sodium salt hydrate, 120 
mecillinam, methicillin sodium salt, nafcillin sodium salt monohydrate, oxacillin sodium salt 121 
monohydrate, penicillin V potassium salt, cefalonium hydrate, ceftiofur, cephapirin sodium, 122 
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biapenem, doripenem monohydrate, meropenem trihydrate and faropenem sodium hydrate 123 
were obtained from Sigma-Aldrich. Ceftiofur metabolites, namely desfuroylceftiofur cysteine 124 
disulfide (DCCD) and desfuroylceftiofur dimer (DCD) were kindly provided by Zoetis 125 
(Kalamazoo, MI, USA). Amoxicillin trihydrate, penicillin G potassium salt, piperacillin, 126 
ticarcillin monosodium, cefadroxil hydrate, cefazolin sodium salt, cefoperazone sodium salt, 127 
cefotaxime sodium salt, cefquinome sulphate, cefuroxime sodium salt, cephalexin 128 
monohydrate and imipenem were purchased from LGC Standards (Teddington, Middlesex, 129 
UK). Cefacetrile, desacetyl cephapirin (DAC) sodium salt, ertapenem disodium 90%, 130 
amoxicillin-d4, ampicillin-d5, benzyl penicillanate-d7 potassium salt (penicillin G-d7), 131 
nafcillin-d5 sodium salt, penicillin V-d5, cefadroxil-d4 (major), cefazolin-
13C2
15N sodium salt, 132 
cefquinome-d7 hydroiodide (90%), cephalexin-d5 hydrate, DAC-d6 sodium salt (major), 133 
DCCD-d3, meropenem-d6 >90% and piperacillin-d5 were supplied by Toronto Research 134 
Chemicals (Toronto, ON, Canada). 135 
 136 
2.2. Preparation of standards 137 
Individual stock solutions were prepared as described by Di Rocco et al. [11] by dissolving 138 
the appropriate amount of standards in H2O:MeCN (75:25, v/v), H2O:MeCN (50:50, v/v) or 139 
DMSO, depending on their solubility. In addition, ceftiofur was dissolved in DMSO at a 140 
concentration of 0.5 mg mL-1, while the internal standards cefquinome-d7, meropenem-d6 and 141 
piperacillin-d5 were dissolved in DMSO at a concentration of 1 mg mL
-1. Stock solutions 142 
were found to be stable for at least 12 months when stored in 2.5 mL aliquots in 15 mL 143 
polypropylene tubes at -80°C, with the exception of DCD and mecillinam, which were stable 144 
for four and six months only, respectively. 145 
As described in Online Resources 1 and 2 (supplementary materials), the β-lactam stock 146 
solutions were organised in three different groups, and an appropriate volume of each stock 147 
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was diluted in water in order to obtain three separate intermediate mixed solutions (IS1-3) 148 
containing the β-lactams at concentrations ranging from 4.0 µg mL-1 to 50 µg mL-1. 149 
Subsequently, the intermediate solutions were combined and further diluted in water to obtain 150 
eight working standard solutions (WSS1-8). An appropriate volume of each internal standard 151 
stock solution was diluted directly in water or through intermediates (IS4-7) to obtain a 152 
mixed internal standard solution at concentrations ranging from 0.080 µg mL-1 to 2.0 µg mL-1 153 
(Online Resources 3 and 4, supplementary materials). Working solutions were stored at -154 
80°C and prepared monthly. 155 
 156 
2.3. Milk samples 157 
Raw bovine milk samples were obtained from different Irish farms and stored at -80°C prior 158 
to analysis. The samples were subsequently tested by applying the proposed method, found to 159 
be drug-free and used as negative controls. 160 
 161 
2.4. Preparation of extracted matrix calibrants and recovery controls 162 
Extracted milk matrix calibrants were prepared by fortifying negative samples (2 g ± 0.01 g) 163 
prior to extraction with 100 μL of each working standard solution, in order to give eight point 164 
calibration curves in the ranges reported in Table 1. 165 
Recovery controls were prepared by spiking four negative milk samples post-extraction, two 166 
with 100 μL of WSS2 and two with 100 μL of WSS7, in order to monitor for loss of analytes 167 
during sample preparation and evaluate the extraction efficiency for each analyte at a low and 168 
a high concentration over the calibration range of the method.  169 
 170 
2.5. Sample preparation 171 
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Samples (2 g ± 0.01 g) were weighed into a polypropylene centrifuge tube (50 mL). A 100 172 
µL volume of the mixed internal standard solution was added to all calibrants, recovery 173 
controls and test samples. Subsequently, the samples were gently shaken for few seconds and 174 
allowed to stand for 15 min. A volume of water (0.9 mL) was added to all calibrants, while 1 175 
mL of water was added to the recovery controls and test samples. A volume of MeCN (7 mL) 176 
was added to all tubes, which were then vortexed for 1 min using a multi-tube vortexer. The 177 
samples were centrifuged for 15 min at 2842×g (4°C), and the supernatant was subsequently 178 
decanted into a 50 mL d-SPE polypropylene tube containing 500 mg of endcapped C18 179 
sorbent. The tubes were vortexed (40 s) and centrifuged for 15 min at 2842×g (4°C). After 180 
centrifugation, the entire supernatant was transferred into a 15 mL polypropylene tube using a 181 
mechanical pipette, and evaporated under nitrogen on a TurboVap at 40°C to a final aqueous 182 
volume of <1 mL (which took approximately 70 min). The volume was then made up to 1 183 
mL with water. The extracts were vortexed for 10 s and centrifuged for 15 min at 2842×g 184 
(4°C). A 400 µL aliquot of the final extract was transferred into syringeless mini-uniprep 185 
PTFE devices, filtered and injected into the UHPLC-MS/MS system.  186 
 187 
2.6. Optimisation of MS/MS conditions 188 
In order to identify precursor and product ions, tuning was performed on an Agilent 6470 189 
triple quadrupole mass spectrometer by injecting 1 µL of 1 µg mL-1 aqueous solutions of 190 
standards and internal standards, with mobile phase A:B (50:50, v/v) at a flow rate of 0.2 mL 191 
min-1. The selected transitions are presented in Table 2. An optimisation of the source 192 
parameters was subsequently performed to maximize the sensitivity achieved for each 193 
compound. 194 
 195 
2.7. UHPLC-MS/MS conditions 196 
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Analysis was performed using an Agilent 1290 Infinity II UHPLC system coupled to an 197 
Agilent 6470 triple quadrupole mass spectrometer (Agilent Technologies Ltd, Cork, Ireland) 198 
equipped with jet stream electrospray ionisation (AJS ESI) probe, and controlled by an 199 
Agilent MassHunter software. Chromatography was achieved on an Agilent Zorbax Eclipse 200 
Plus Phenyl-Hexyl Rapid Resolution HD analytical column (3.0×100 mm, 1.8 µm particle 201 
size) fitted with an in-line filter with a 0.2 µm pore size, using a binary gradient comprising 202 
of 0.01% HCOOH and 0.2 mM ammonium acetate in H2O (mobile phase A) and 0.01% 203 
HCOOH in MeCN (mobile phase B). The flow rate was set at 0.4 mL min-1. The total run 204 
time was 12 min, and the gradient profile as follows: (1) 0 – 0.5 min, 100% A; (2) 0.5 – 2.5 205 
min, linear decrease to 80% A; (3) 2.5 – 7.5 min, linear decrease to 20% A; (4) 7.5 – 7.6 min, 206 
linear decrease to 0% A; (5) 7.6 – 9.0 min, hold at 0% A to wash the column with organic 207 
mobile phase B; (6) 9.0 – 9.1 min, linear increase to 100% A, which was held for 2.9 min to 208 
allow re-equilibration of the column. The column compartment was maintained at 30°C, 209 
while the multisampler temperature was set at 7°C. The injection volume was 10 µL. The 210 
autosampler was rinsed after each injection using a solution of H2O:MeCN (50:50, v/v). A 211 
divert valve was used to reduce source contamination from undesired matrix components 212 
(solvent delay: [a] 0 – 2.56 min; [b] 7.77 – 12 min). 213 
The mass spectrometer was operated in positive ESI mode (ESI(+)). The optimised source 214 
operating parameters were: gas temperature, 150°C; sheath gas temperature, 400°C; gas flow, 215 
9 L min-1; sheath gas flow, 11 L min-1; nebulizer, 45 psi; capillary, 5250 V; nozzle voltage, 216 
1000 V. The cycle time was set at 0.5 s.  217 
 218 
2.8. Method validation 219 
The method was validated as described by Di Rocco et al. [11], following 2002/657/EC 220 
guidelines [12]. Trueness, within-laboratory repeatability (WLr) and within-laboratory 221 
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reproducibility (WLR) were assessed for the MRL-substances and the metabolites at 0.5, 1 222 
and 1.5 times the MRLs set by current legislation [3]. For the non MRL-substances, TLs were 223 
established based on the sensitivity achieved by the method for each compound, and 224 
validation was performed at 0.5, 1 and 1.5 times the TLs. The WLr study was performed on 225 
three different days by the same analyst, using the same negative sample and by fortifying 226 
eight replicates for each validation level. The WLR study was performed on three separate 227 
days by three different analysts by fortifying 24 different control milk samples (eight samples 228 
for each validation level). These samples were obtained from bulk tanks of 24 different Irish 229 
farms. 230 
2.9. Data analysis 231 
Linear regression of the calibration data was performed with a weighing factor of 1/x2. 232 
Thirteen internal standards were used for quantitation purposes. Each labelled compound was 233 
employed for its corresponding analyte. In addition, results for cefacetrile, ertapenem and 234 
mecillinam were corrected using cefadroxil-d4; for cefalonium, cefotaxime, cefuroxime and 235 
faropenem using cefquinome-d7; for cloxacillin and dicloxacillin using nafcillin-d5; for 236 
doripenem using amoxicillin-d4. Among the available labelled compounds, no suitable 237 
internal standards could be identified for biapenem, imipenem, cefoperazone, ceftiofur, 238 
cephapirin, DCD, methicillin, oxacillin and ticarcillin during matrix effect investigations, 239 








3.1. Method development 246 
 247 
3.1.1. Chromatographic separation 248 
A chromatographic separation based on a method previously published by our group for the 249 
analysis of β-lactam residues in bovine muscle was initially evaluated [11]. The application 250 
of this method identified isobaric interferences between two pairs of analytes, namely 251 
amoxicillin-cefadroxil and ampicillin-cephalexin, most likely due to the similar masses of 252 
these compounds and their isotopes (Figure 1). Additionally, despite the attempt to select 253 
unique transitions for each analyte, the same product ions were obtained in CID experiments 254 
(Figure 1 and Figure 2), most of which have been characterised in the literature [13]. This led 255 
to interference from cefadroxil and cephalexin in the analysis of amoxicillin and ampicillin, 256 
respectively, resulting in inaccuracy for quantitation purpose or ambiguity in analyte 257 
confirmation. This did not represent a problem in the previously developed method for β-258 
lactam analysis in bovine muscle [11], as the same, or very similar, calibration ranges could 259 
be established for the two pairs of analytes, resulting in negligible interference. However, in 260 
this work, different calibration ranges had to be established to allow the analysis of milk at 261 
very different MRL levels (range 4-125 μg kg-1, Table 1), and to ensure adequate MS 262 
sensitivity for cefadroxil. If these compounds are not chromatographically resolved in multi-263 
residue analysis, it will result in underestimation of amoxicillin and ampicillin concentrations 264 
in test samples, which could potentially lead to false negative results. 265 
Three potential alternative approaches could be considered: (1) the validation of a low-level 266 
screening method for cephalexin and cefadroxil, and a separate high level quantitative 267 
method to be applied in case of positive samples found; (2) a separate validation for the two 268 
analytes of each pair; (3) the use of high-resolution mass spectrometry (HRMS), which would 269 
offer high mass accuracy, allowing to easily distinguish those analytes. However, approaches 270 
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(1) and (2) would be more expensive and time-consuming when applying the method for 271 
routine analysis, while approach (3) would imply a higher cost compared to low resolution 272 
MS, and it could also be not always available in routine laboratories. Therefore, a range of 273 
different chromatographic conditions were evaluated in order to achieve separation of each 274 
pair of cross-interfering analytes. Additional objectives of this research were the 275 
improvement of column retention of early eluting polar analytes (namely imipenem and 276 
biapenem), and the reduction of the chromatographic cycle to <18 min total run time, mostly 277 
due to the long re-equilibration time.  278 
A range of different mobile phase additives and concentrations (0.01-0.1% formic acid and 279 
acetic acid; 0.2-50 mM ammonium formate and ammonium acetate) were initially tested on 280 
the CSH C18 analytical column employed for the meat method [11]. However, it became 281 
quickly apparent that conventional stationary phases lacked the selectivity to separate both 282 
co-eluting pairs when trying to maintain a relatively short total run time. In fact, our previous 283 
research had already shown that other columns such as BEH C18 and HSS T3 could separate 284 
amoxicillin from cefadroxil, but not ampicillin from cephalexin [11]. Therefore, the 285 
following alternative columns were assessed based on solvent and additive compatibilities 286 
and physico-chemical properties of the compounds: 287 
 Phenomenex Kinetex PFP 100 × 2.1 mm, 1.7 μm;  288 
 Fortis SpeedCore PFP 100 × 2.1 mm, 2.6 μm;  289 
 UCT Selectra PFPP 10 cm × 2.1 mm, 3 μm;  290 
 Sielc Obelisc R 2.1 × 100 mm, 5 μm;  291 
 Imtakt Scherzo SS-C18 100 × 2 mm, 3 μm;  292 
 Imtakt Scherzo SM-C18 100 × 2 mm, 3 μm;  293 
 Agilent Zorbax Eclipse Plus Phenyl-Hexyl RRHD 3.0 × 100 mm, 1.8 μm;  294 
 Fortis SpeedCore DiPhenyl 100 × 2.1 mm, 2.6 μm. 295 
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Separation was considered as successfully achieved if peak resolution (Rs) was ≥1.5 [14].  296 
Fluorinated stationary phases, especially pentafluorophenyl (PFP) moieties, are often used as 297 
alternatives to common C18 and C8 phases to promote dipole, π-π and strong ion-exchange 298 
interactions. In this study, these columns did not show satisfactory separation of the co-299 
eluting analytes, with the exception of SpeedCore PFP, which could separate amoxicillin and 300 
cefadroxil, but not ampicillin and cephalexin. Multi-mode columns were also evaluated, 301 
including Obelisc R, Scherzo SS-C18 and Scherzo SM-C18. These columns allow the 302 
separation of analytes using different chromatographic separation processes, namely 303 
partition-based retention and ion exchange. The Obelisc R was found to provide satisfactory 304 
separation of ampicillin and cephalexin, but could not resolve amoxicillin from cefadroxil. In 305 
addition, peak shape was found to be unsatisfactory. In contrast, the Scherzo columns 306 
separated amoxicillin and cefadroxil, but did not resolve the other problematic pair, and poor 307 
sensitivity was also obtained overall for all analytes due to the need to include 50 mM 308 
ammonium formate in the mobile phase.  309 
Considering the chemical structure of the problematic analytes, the phenyl-hexyl and 310 
diphenyl columns were evaluated due to their ability for improving the selectivity of aromatic 311 
compounds [9] and the retention of highly polar drugs [8]. In this study, these were the only 312 
two columns that achieved satisfactory separation for both pairs of analytes (Figure 2). 313 
However, the phenyl-hexyl column combined with a water/acetonitrile mobile phase seemed 314 
to be the most reasonable choice because it also provided better retention of the more polar 315 
analytes (which started to be eluted after 3 min compared to 2.3 min on the C18 column), gave 316 
better overall sensitivity, and allowed reduction of the total run time to 12 min.  317 
Subsequently, three different batches of the phenyl-hexyl column were tested to verify 318 
reproducibility of the retention times. The maximum standard deviation (SD, n=3) was ±0.05 319 




3.1.2. Storage of milk samples 322 
A number of stability studies have been reported in the literature for β-lactam antibiotics in 323 
milk samples. Hou et al. [15] investigated the stability of 10 cephalosporins and desacetyl 324 
cephapirin in fortified bovine milk samples stored at -20ºC over a period of 14 days. 325 
Although no degradation was observed after seven days, significant loss was reported for 326 
cephalexin, ceftiofur and cefacetrile on day 14. Riediker et al. [16] investigated the stability 327 
of five penicillins, namely amoxicillin, ampicillin, cloxacillin, oxacillin, and penicillin G, in 328 
fortified milk samples at different storage temperatures (+4, -20 and -76ºC) over a period of 329 
28 days. The authors observed that all analytes were stable for a maximum of three days if 330 
samples were stored at +4ºC. When stored at -20ºC, amoxicillin and ampicillin were the only 331 
two analytes stable throughout the chosen storage period, while the other compounds 332 
underwent between 10-20% degradation after three days. No degradation was reported for 333 
samples stored at -80ºC throughout the entire storage period. However, the authors employed 334 
pasteurized milk, rather than raw milk. A number of studies have also been reported for β-335 
lactam stock solutions, highlighting the challenge in the analysis of these compounds and the 336 
importance of storage temperatures below -70ºC [17-19, 11]. As a consequence, it was 337 
decided to store all the milk samples used for the proposed study at -80ºC to avoid potential 338 
degradation of the residues, if present. 339 
3.1.3. Sample preparation 340 
In order to isolate the β-lactam residues and precipitate milk proteins, two different extraction 341 
solutions (8 mL of MeCN and 8 mL of MeCN:H2O (7:1, v/v)) were investigated, and absolute 342 
recoveries evaluated as described by Di Rocco et al. [11]. The use of MeCN only gave lower 343 
recoveries for the more polar penicillins and cephalosporins, the carbapenems, faropenem 344 
and the ceftiofur-related metabolites, providing overall results ranging from 11% (ertapenem) 345 
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to 92% (methicillin). The polarity of the solution was subsequently increased with the 346 
addition of 1 mL of water, which significantly improved the efficiency of the extraction and 347 
provided satisfactory absolute recoveries ranging from 60% (amoxicillin and ertapenem) to 348 
118% (methicillin) (Figure 3). 349 
Solvent evaporation and analyte concentration under nitrogen were required to achieve 350 
satisfactory sensitivity for the regulated compounds with low MRLs. The importance of 351 
temperature control during sample preparation and UHPLC-MS/MS analysis for β-lactams 352 
has already been deeply investigated [11]. Therefore, it was decided to keep the solvent 353 
evaporation temperature at 40ºC, while dynamically increasing the nitrogen gas pressure 354 
from 10 to 20 psi. This allowed the evaporation of MeCN in approximately 70 min. On the 355 
other hand, the C18 d-SPE clean-up and the use of internal standards avoided adverse matrix 356 
effects that could be caused by a significant amount of matrix components in the final extract.  357 
 358 
3.2. Method validation 359 
 360 
3.2.1. Confirmatory criteria, selectivity, linearity, LODs and LOQs  361 
As outlined in the 2002/657/EC guidelines, three identification points are required by a 362 
confirmatory method for group B substances. A minimum of four identification points were 363 
obtained for all analytes in the proposed work. In addition, retention time and ion ratio 364 
deviations were all within the maximum permitted tolerances [12]. The selectivity study 365 
showed no interferences when injecting all standards and internal standards individually, and 366 
no matrix undesired peaks when injecting 25 blank milk samples obtained from different 367 
sources. Satisfactory linearity was achieved over the calibration range of the method, as R2 ≥ 368 
0.98 were obtained for all analytes, with a five-point calibration curve (excluding the origin) 369 
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achieved for all compounds and individual residuals in the ± 20% range of deviation 370 
tolerance from the calibration curve.  371 
Although the assessment of the LODs and LOQs is not required by 2002/657/EC guidelines, 372 
these parameters were estimated based on the lowest signal-to-noise (S/N) ratio obtained for 373 
the first calibration point among the six validation runs (Table 3).  The LOD and LOQ values 374 
were set at those concentration levels for which the S/N ratio for the qualifier ion would be at 375 
least 3 and 10, respectively. The estimation was made based on the S/N ratio of the least 376 
abundant ion in order to take into account the variability that could be observed between 377 
different milk samples, and report a more realistic estimation of the LOD and LOQ values. 378 
The estimated LODs were in the range 0.0090-1.5 μg kg-1, while LOQs ranged from 0.030 to 379 
5.0 μg kg-1 (Table 3). 380 
 381 
3.2.2. Matrix effects 382 
As reported in Table 3, the matrix effect study showed matrix enhancement from 0.25% 383 
(ertapenem) to 65% (faropenem) for all compounds, except for amoxicillin, mecillinam, 384 
cefacetrile, cefadroxil, DCD, biapenem and doripenem, for which matrix suppression was 385 
observed (range 3.6-29.4%). It is particularly important to evaluate the effect of matrix 386 
variability for the quantitation of those analytes that show matrix enhancement, due to the 387 
fact that a positive sample could lead to a false non-compliant result. Therefore, 25 milk 388 
samples from different origin were fortified post-extraction at the MRLs/TLs and compared 389 
to a mixture of standards in solvent at the same concentrations. When available, the 390 
corresponding labelled compound was used as an internal standard in the quantitation of the 391 
analyte. The effect of each internal standard on the quantitation of the other β-lactams was 392 
also evaluated so that a suitable internal standard could be identified. Variability between the 393 
different samples was significantly reduced when using a labelled compound, with relative 394 
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standard deviation (RSD%) values <16.4% except for faropenem (38.9%), for which the use 395 
of cefquinome-d7 did not show significant improvement. However, quantitation against the 396 
internal standard was applied to compensate for any loss during sample preparation or 397 
instrument variability. Although no suitable internal standards could be identified for 398 
methicillin, oxacillin, ticarcillin, cephapirin, cefoperazone, ceftiofur, DCD, biapenem and 399 
imipenem, variability was ≤ 22.3%, with the only exceptions of ceftiofur (28.2%) and DCD 400 
(27.3%).  401 
 402 
3.2.3. Trueness, precision, CCα and CCβ 403 
As reported in Table 4, the trueness under WLr conditions was satisfactory and within the 404 
range 91-110% for most of the compounds, with the only exceptions of oxacillin and DCD at 405 
1.5 MRL level, for which the trueness was slightly above the maximum acceptable values 406 
(115% and 111%, respectively) [12]. The trueness was also satisfactory for the majority of 407 
substances under WLR conditions (range of 91-110%). The exceptions were at 1.5 MRL/TL 408 
for ticarcillin (119%), cephapirin (112%), cefoperazone (121%) and DCD (130%), for which 409 
no suitable internal standards could be identified during the method development work. 410 
Precision for most analytes satisfied the 2002/657/EC requirements, and was ≤ 23% for the 411 
majority of analytes. Under WLr conditions, CVs% were in the range 0.86-9.7%, except for 412 
DCD at 0.5 MRL, for which CV was 17.7%. Under WLR studies, CVs ranged from 1.4% to 413 
21.8% for most of the compounds. Precision was still acceptable for faropenem at 0.5 TL and 414 
TL (24.6% and 25%, respectively), and for cefotaxime and ticarcillin at TL (25.5% and 415 
29.9%, respectively), as it was found to be lower than the maximum coefficient of variations 416 
(CVs%) calculated by the Horwitz equation [12]. The precision of the method was above 417 
maximum CVs for DCD (25.3% at 0.5 MRL and 29.4% at MRL), ticarcillin (38.6% at 0.5 TL 418 
and 36.0% at 1.5 TL) and cefoperazone at all validation levels (34.7% at 0.5 MRL, 29.3% at 419 
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MRL and 35.1% at 1.5 MRL). This issue could be addressed by implementing suitable 420 
corresponding labelled internal standards into the method. CCα values ranged from 2.1 µg 421 
kg-1 (mecillinam) to 133 µg kg-1 (cefacetrile), depending on the analyte.  422 
In our previous work [11] and in the literature [20], a rapid conversion of cephapirin to 423 
desacetyl cephapirin occurred in fortified muscle samples and kidney homogenate, while this 424 
conversion was not observed in milk samples. Therefore, in contrast to the meat method [11], 425 
both cephapirin and its metabolite could be included and successfully validated in the 426 
proposed work, allowing compliance with current legislation [3]. 427 
 428 
3.3. Comparison with existing methods 429 
A review of the LC-MS published methods that were specifically developed for the analysis 430 
of β-lactam residues in milk showed that most of the sample pretreatments employ SPE on 431 
C18 or Oasis HLB cartridges [7, 21, 6, 22], a relatively time-consuming and expensive 432 
procedure, with significant amounts of solvents required [23].  Baenza et al. [24] applied 433 
molecularly imprinted polymers (MIPs) for the determination of cephalosporin residues in 434 
bovine milk. However, the method included six cephalosporins only, with mean recoveries in 435 
the range 15-100%. .  Van Holthoon et al. [25] described a LC-MS/MS method for eight 436 
penicillins in milk, with a sample pretreatment that required derivatisation with piperidine 437 
followed by SPE. Online SPE, ultrasound-assisted matrix solid phase dispersion (MSPD) 438 
combined with QuEChERS (Quick, Easy, Cheap, Effective, Rugged and Safe) technique, and 439 
dispersive liquid-liquid microextraction (DLLME) have also been reported for the analysis of 440 
β-lactams in milk [4, 26, 23]. These methods include a limited number of penicillins and 441 
cephalosporins, and do not target the main metabolites. An alkaline QuEChERS extraction 442 
employing a mixture of anhydrous sodium sulphate (Na2SO4) and sodium chloride (NaCl) 443 
with mechanical shaking was applied by Bessaire et al. [27] for the analysis of 23 β-lactams, 444 
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including desacetyl cephapirin, in foods of animal origin (eggs, raw milk, processed dairy 445 
ingredients, baby foods, meat- and fish-based products). This work included a quite wide 446 
range of analytes, but it was only applied for screening purposes, as significant losses of the 447 
compounds were observed during sample preparation, with absolute recoveries in the range 448 
8-55%, especially for the more polar analytes. 449 
Among the most recent published methods, the majority of authors focused on the inclusion 450 
of a wide range of veterinary drugs from different classes. Turnipseed et al. [28] developed a 451 
quadrupole time-of-flight (Q-TOF) LC-MS method for four different classes of veterinary 452 
active compounds, including three penicillins and one cephalosporin, in milk. The samples 453 
were extracted using acetonitrile, and clean-up was subsequently performed using 3000Da 454 
molecular weight cut-off centrifuge filters. Zhu et al. [29] developed a LC-MS/MS method 455 
for 88 veterinary drugs from eight different families, including eight penicillins. Samples 456 
were ultrasonic extracted, and subsequently purified using TurboFlow online SPE. Castilla-457 
Fernández et al. [30] evaluated different sample preparation procedures for the determination 458 
of 66 veterinary drugs, including a fast pass-through SPE clean-up on HLB PRiME 459 
cartridges. The study focused on more than 14 different drug classes, and included three 460 
penicillins and three cephalosporins. Despite the possibility to monitor more drug families 461 
simultaneously and the fact that these methods are faster, less time-consuming and cheaper 462 
than single-class methods, they included only a limited number of β-lactams. 463 
The proposed study employs a simple and fast dSPE-based sample preparation procedure for 464 
the extraction of 32 β-lactam residues from milk matrix, including the carbapenems for 465 
which, to the best of our knowledge, there are no other published methods. Absolute 466 
recoveries for the 32 compounds ranged from 60 to 118%, demonstrating the efficiency of 467 
the extraction procedure. As shown from validation results, the method is also able to 468 
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accurately quantify the residues, and matches the recommended performance criteria reported 469 
by 2002/657 (EC) guidelines [12].  470 
One of the main objectives of this work was also to develop a highly selective method. Due 471 
to the class-specific fragments obtained for many of the β-lactams, it is important to underline 472 
the necessity of assessing selectivity in MS/MS analysis, discouraging the common practice 473 
of simply choosing the most intense product ions rather than the most distinctive [13]. The 474 
choice of unique product ions represents the easiest approach to selectivity issues. However, 475 
this is not always achievable for compounds of similar masses and if similar products are 476 
generated in CID experiments. Therefore, an efficient chromatography must be developed in 477 
order to obtain optimal separation. The majority of methods published for the analysis of β-478 
lactams in milk include penicillins [31, 32, 25, 33] or cephalosporins [24, 15, 26, 1, 34] only. 479 
Among the methods that target at least one of the two pairs of problematic analytes, 480 
Daeseleire et al. [35] obtained satisfactory resolution for ampicillin and cephalexin on a 481 
HPLC Alltima C18 column using a water/acetonitrile mobile phase with formic acid. 482 
Although very good separation was achieved for the two compounds (1.76 min of 483 
difference), a 150 mm chromatographic column and a longer gradient had to be employed. As 484 
a consequence, the total run time for the separation of the 11 analytes included in the method 485 
had to be set to 17 min, considering that a final hold of 7.2 min at 100% mobile phase A was 486 
required for the re-equilibration of the system. Similarly, Becker et al. [20] employed a 487 
water/methanol mobile phase with formic acid on a phenylether column for the separation of 488 
15 penicillins and cephalosporins, including ampicillin and cephalexin. In their method, a 250 489 
mm HPLC column was used, with a total run time of 52 min, including a binary gradient 490 
extended over a 22 min time, a 15 min hold at 90% mobile phase B for washing the column, 491 
and a final hold at 100% mobile A for system re-equilibration. For the majority of published 492 
methods, very similar retention times were obtained for the two problematic pairs of analytes 493 
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on C18 stationary phases [18, 36, 37]. However, the selectivity/specificity studies aimed to 494 
identify the presence of undesired peaks from the matrix by analysing blank samples, but did 495 
not investigate the possible interference between the different standards. The research 496 
proposed in this work underwent a detailed study of possible interferences between all 497 
analytes, which is necessary for multi-residue methods in the presence of compounds with 498 
similar physico-chemical properties and behaviour, and addressed the issue by developing an 499 





The development of a sensitive UHPLC-MS/MS method for the simultaneous analysis of 32 505 
β-lactam antibiotic residues in milk was presented. The method included a wide range of 506 
unique compounds which are normally not analysed in routine laboratories. Additionally, to 507 
the best of our knowledge, this is the first time that a method for carbapenems and faropenem 508 
in milk samples is reported. Our research also showed the importance of assessing selectivity 509 
when validating a multi-residue method that includes compounds with similar masses and 510 
structures. Isobaric interferences were observed between amoxicillin and cefadroxil and 511 
between ampicillin and cephalexin, most likely due to naturally occurring isotopes. The 512 
method presented in this work addressed this problem by achieving satisfactory 513 
chromatographic selectivity through the use of a novel phenyl-hexyl stationary phase, which 514 
was demonstrated to be a valid alternative to C18 analytical columns to obtain the efficient 515 
separation of these β-lactams. The sample preparation procedure involved a simple and fast 516 
d-SPE clean-up step, and allowed a single analyst the extraction of 60-70 milk samples per 517 
day. The results of the validation study showed a high degree of accuracy in the quantitation 518 
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of the majority of analytes included. In routine conditions, this method represents an easy and 519 
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Table captions 671 
 672 
Table 1 Maximum Residue Limits (MRLs)/Target Levels (TLs) for β-lactam antibiotics in 673 
milk and calibration ranges of the proposed method 674 
Table 2 UHPLC-MS/MS conditions for β-lactams in milk 675 
Table 3 Calibration ranges, LODs, LOQs and matrix effect data. Positive values indicate ion 676 
suppression, while negative values indicate matrix enhancement 677 
Table 4 Trueness (%), precision (%), CCα and CCβ values for β-lactam compounds in raw 678 





Figure captions 682 
Fig1(a) MS(/MS) spectra of amoxicillin and cefadroxil. The same product ions (114 m/z, 208 683 
m/z and 349 m/z) were generated in CID experiments from the 366 m/z precursor mass 684 
Fig1(b) MS(/MS) spectra of ampicillin and cephalexin. The same product ions (106 m/z, 174 685 
m/z and 192 m/z) were generated in CID experiments from the 350 m/z precursor mass 686 
Fig2(a) Injections of individual standards of amoxicillin and cefadroxil at 250 ng mL-1. 687 
Chromatograms show the interference from cefadroxil in the analysis of amoxicillin on the 688 
CSH C18 column (A and B), while analytes are resolved on the phenyl-hexyl column (C and 689 
D) 690 
Fig2(b) Injections of individual standards of ampicillin and cephalexin at 250 ng mL-1. 691 
Chromatograms show the interference from cephalexin in the analysis of ampicillin on the 692 
CSH C18 column (A and B), while analytes are resolved on the phenyl-hexyl column (C and 693 
D) 694 
Fig3 Absolute recoveries (efficiency of extraction) and standard deviations (shown by error 695 
bars, n=3) obtained for β-lactam compounds when using 8 mL of MeCN and 8 mL of 696 
MeCN:H2O (7/1, v/v) as extraction solutions. Results for cephapirin and ceftiofur are not 697 
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Online Resource 1 Flow diagram showing the preparation of the working standard solutions 703 
Online Resource 2 Concentrations of the β-lactams in the three intermediate mixed solutions 704 
and range of concentrations in the final working standard solutions 705 
Online Resource 3 Flow diagram showing the preparation of the mixed internal standard 706 
solution 707 
Online Resource 4 Concentrations of the β-lactam internal standards in the intermediate and 708 










Amoxicillin All food producing species 4(a) 1-8 
Ampicillin All food producing species 4(a) 1-8 
Cloxacillin All food producing species 30(a) 7.5-60 
Dicloxacillin All food producing species 30(a) 7.5-60 
Mecillinam Bovine 2(b) 0.5-4 
Methicillin - 2(b) 0.5-4 
Nafcillin All ruminants 30(a) 7.5-60 
Oxacillin All food producing species 30(a) 7.5-60 
Penicillin G All mammalian food producing species 4(a) 1-8 
Penicillin V - 4(b) 1-8 
Piperacillin - 4(b) 1-8 
Ticarcillin - 10(b) 2.5-20 
Cefacetrile Bovine 125(a) 31.25-250 
Cefadroxil - 20(b) 5-40 
Cephalexin Bovine 100(a) 25-200 
Cephapirin Bovine 60(a) 15-120 
Cefalonium Bovine 20(a) 5-40 
Cefazolin Bovine, ovine, caprine 50(a) 12.5-100 
Cefoperazone Bovine 50(a) 12.5-100 
Cefotaxime - 8(b) 2-16 
Cefquinome Bovine 20(a) 5-40 
Ceftiofur All mammalian food producing species 100(a) 25-200 
Cefuroxime - 20(b) 5-40 
Desacetyl cephapirin Bovine 60(a) 15-120 
Desfuroylceftiofur cysteine disulfide All mammalian food producing species 100(a) 25-200 
Desfuroylceftiofur dimer All mammalian food producing species 100(a) 25-200 
Biapenem - 6(b) 1.5-12 
Doripenem - 40(b) 10-80 
Ertapenem - 20(b) 5-40 
Imipenem - 20(b) 5-40 
Meropenem - 10(b) 2.5-20 
Faropenem - 4(b) 1-8 




















Imipenem [M+H]+ 3.05 1 300.1 141.9a/123.9 110 33/45 4 
Biapenem [M+H]+ 3.11 1 351.1 110.0a/265.0 110 17/13 4 
Amoxicillin [M+H]+ 3.22 1 366.1 349.0a/113.9 110 5/21 4 
Amoxicillin-d4 [M+H]+ 3.21 1 370.1 353.0 110 5 4 
DAC [M+H]+ 3.29 1 382.1 151.9a/111.9 140 33/29 4 
DAC-d6 [M+H]+ 3.28 1 388.1 232.0 140 17 4 
Doripenem [M+H]+ 3.51 1 421.1 274.0a/112.0 140 17/50 4 
Cefadroxil [M+H]+ 3.53 1 364.1 208.0a/113.9 80 5/17 4 
Cefadroxil-d4 [M+H]+ 3.53 1 368.1 212.0 80 5 4 
Meropenem [M+H]+ 3.69 1 384.2 141.0a/340.1 140 13/9 4 
Meropenem-d6 [M+H]+ 3.68 1 390.2 147.2 110 13 4 
DCCD [M+H]+ 3.83 1 549.0 182.9a/241.0 170 25/21 5 
DCCD-d3 [M+H]+ 3.82 1 552.1 244.0 170 21 5 
Cephapirin [M+H]+ 3.84 1 424.1 292.0a/151.9 140 13/25 4 
Ampicillin [M+H]+ 3.94 1 350.1 106.1a/192.0 110 21/13 4 
Ampicillin-d5 [M+H]+ 3.92 1 355.2 111.0 110 21 4 
Cephalexin [M+H]+ 4.13 1 348.1 157.9a/174.0 110 5/13 4 
Cephalexin-d5 [M+H]+ 4.12 1 353.1 158.0 110 5 4 
Ertapenem [M+H]+ 4.22 1 476.2 432.0a/233.0 140 5/17 4 
Cefacetrile [M+NH4]+ 4.27 1 357.1 280.0a/251.9 80 5/13 4 
Cefquinome [M+H]+ 4.30 1 529.1 134.0a/166.9 140 13/25 4 
Cefquinome-d7 [M+H]+ 4.29 1 536.2 141.1 110 13 4 
Mecillinam [M+H]+ 4.41 1 326.2 167.0a/139.0 170 25/37 4 
Cefalonium [M+H]+ 4.42 1 459.1 151.9a/337.0 110 17/5 5 
Cefotaxime [M+H]+ 4.48 1 456.1 396.0a/125.0 140 9/50 4 
Cefazolin [M+H]+ 4.67 1 455.0 323.0a/155.9 110 9/13 4 
Cefazolin-13C215N [M+H]+ 4.67 1 458.1 326.0 110 5 4 
Cefuroxime [M+NH4]+ 4.85 1 442.1 364.0a/336.1 110 5/13 4 
Faropenem [M+NH4]+ 4.99 1 303.1 200.0a/182.0 80 5/21 4 
Cefoperazone [M+H]+ 5.16 1 646.2 143.0a/530.0 170 41/9 4 
Ticarcillin [M+H]+ 5.18 1 385.1 159.9a/114.0 140 9/45 4 
DCD [M+2H]2+ 5.26 1 429.0 182.9a/397.0 110 21/9 5 
Ceftiofur [M+H]+ 5.68 1 524.0 241.0a/125.3 170 17/50 4 
Methicillin [M+H]+ 5.77 1 381.1 164.9a/222.0 140 21/17 4 
Piperacillin [M+H]+ 5.82 1 518.2 143.0a/159.9 170 21/5 4 
Piperacillin-d5 [M+H]+ 5.81 1 523.2 148.0 170 17 5 
Penicillin G [M+H]+ 5.98 1 335.1 176.0a/160.0 110 13/5 4 
Penicillin G-d7 [M+H]+ 5.95 1 342.2 183.0 110 13 4 
Penicillin V [M+H]+ 6.31 1 351.1 159.9a/114.0 140 5/37 4 
Penicillin V-d5 [M+H]+ 6.29 1 356.1 160.0 140 5 4 
Oxacillin [M+H]+ 6.56 1 402.1 243.0a/114.0 110 9/49 4 
Cloxacillin [M+H]+ 6.85 1 436.1 159.9a/276.9 110 9/13 4 
Nafcillin [M+H]+ 6.93 1 415.1 199.0a/170.9 110 9/45 4 
Nafcillin-d5 [M+H]+ 6.92 1 420.2 204.1 110 9 4 
Dicloxacillin [M+H]+ 7.22 1 470.0 159.9a/310.9 140 9/13 4 
a = Quantifier; RT = Retention Time; FRM = Fragmentor; CE = Collision Energy; CAV = Cell Accelerator Voltage; DAC = 


















Amoxicillin 21(1) 0.15 0.50 28.7 8.2 4.8 
Ampicillin 43(1) 0.075 0.25 -14.5 8.4 4.9 
Cloxacillin 303(7.5) 0.075 0.25 -27.7 16.6 12.9 
Dicloxacillin 107(7.5) 0.20 0.70 -40.4 22.9 13.0 
Mecillinam 167(0.5) 0.0090 0.030 3.6 7.4 4.5 
Methicillin 77(0.5) 0.020 0.065 -54 22.3 - 
Nafcillin 1154(7.5) 0.020 0.065 -34.9 29.1 3.2 
Oxacillin 152(7.5) 0.15 0.50 -9.3 14.5 - 
Penicillin G 154(1) 0.020 0.065 -60 16.4 5.2 
Penicillin V 334(1) 0.0090 0.030 -8.9 7.2 4.1 
Piperacillin 21(1) 0.15 0.50 -35.9 10.1 3.1 
Ticarcillin 52(2.5) 0.15 0.50 -3.6 16.2 - 
Cefacetrile 625(31.25) 0.15 0.50 12.2 8.2 6.8 
Cefadroxil 101(5) 0.15 0.50 29.4 5.9 2.3 
Cephalexin 502(25) 0.15 0.50 -12.5 6.8 3.9 
Cephapirin 1875(15) 0.025 0.080 -2.6 12.4 - 
Cefalonium 333(5) 0.045 0.15 -31.3 16.6 13.4 
Cefazolin 417(12.5) 0.090 0.30 -25.0 26.0 3.7 
Cefoperazone 251(12.5) 0.15 0.50 -46.0 15.5 - 
Cefotaxime 82(2) 0.065 0.25 -19.7 22.4 16.0 
Cefquinome 202(5) 0.065 0.25 -13.4 9.5 3.0 
Ceftiofur 278(25) 0.30 0.90 -55 28.2 - 
Cefuroxime 101(5) 0.15 0.50 -59 18.4 16.4 
DAC 302(15) 0.15 0.50 -3.1 10.8 2.7 
DCCD 102(25) 0.65 2.5 -35.1 9.2 2.6 
DCD 52(25) 1.5 5.0 15.3 27.3 - 
Biapenem 31(1.5) 0.15 0.50 5.8 11.0 - 
Doripenem 52(10) 0.60 2.0 8.3 8.7 6.9 
Ertapenem 26(5) 0.60 2.0 -0.25 6.8 5.8 
Imipenem 103(5) 0.15 0.50 -33.2 17.0 - 
Meropenem 42(2.5) 0.20 0.60 -52 9.2 3.2 
Faropenem 104(1) 0.030 0.10 -65 39.0 38.9 
IS = Internal Standard; ME = Matrix Effect; a = Signal-to-noise ratio for the qualifier ion; b = Results are based on the analysis of 25 
different bovine milk samples. 
Table 4 
Analyte 















Amoxicillin 102 (3.6) 100 (3.4) 100 (3.1) 100 (5.2) 101 (4.8) 99 (2.0) 4.3 4.5 
Ampicillin 103 (3.1) 100 (3.1) 101 (2.0) 99 (4.5) 98 (5.0) 97 (3.5) 4.2 4.5 
Cloxacillin 99 (8.7) 93 (8.5) 91 (5.2) 100 (8.4) 96 (14.2) 94 (10.8) 38.7 49.0 
Dicloxacillin 101 (8.6) 101 (7.9) 100 (5.4) 102 (10.1) 101 (12.4) 100 (6.0) 34.9 39.8 
Mecillinam 101 (3.7) 100 (3.4) 101 (2.8) 103 (10.1) 95 (10.1) 101 (7.0) 2.1 2.4 
Methicillin 106 (6.7) 108 (6.2) 107 (4.3) 91 (14.8) 96 (15.3) 96 (12.4) 2.4 3.0 
Nafcillin 102 (1.8) 101 (1.9) 100 (1.1) 101 (1.9) 101 (1.5) 100 (1.4) 30.8 31.6 
Oxacillin 103 (8.2) 109 (6.6)  115 (5.3) 96 (15.8) 98 (16.0) 100 (9.5) 39.0 47.0 
Penicillin G 100 (3.3) 99 (1.9) 97 (2.5) 99 (3.6) 99 (4.0) 99 (2.6) 4.1 4.4 
Penicillin V 101 (3.3) 100 (2.8) 100 (2.1) 103 (4.2) 101 (2.3) 101 (3.3) 4.1 4.3 
Piperacillin 99 (3.8) 99 (2.5) 99 (1.8) 101 (3.1) 100 (2.5) 99 (1.7) 4.1 4.3 
Ticarcillin 102 (2.9) 102 (4.3) 102 (5.6) 110 (38.6) 105 (29.9) 119 (36.0) 11.8 25.1 
Cefacetrile 97 (4.9) 95 (2.7) 96 (2.5) 97 (6.7) 97 (5.3) 98 (4.9) 133 145 
Cefadroxil 98 (2.9) 100 (2.6) 99 (2.8) 99 (2.8) 100 (3.0) 98 (3.0) 21.0 22.0 
Cephalexin 101 (0.86) 100 (1.1) 100 (1.0) 100 (2.8) 100 (3.2) 100 (1.6) 104 108 
Cephapirin 106 (4.5) 105 (3.3) 102 (2.7) 103 (18.9) 101 (18.4) 112 (15.8) 69 90 
Cefalonium 103 (3.5) 102 (2.6) 101 (2.1) 103 (18.3) 109 (15.3) 106 (10.7) 22.2 27.2 
Cefazolin 100 (1.2) 100 (1.1) 100 (1.2) 100 (2.2) 100 (1.4) 100 (1.9) 51 52 
Cefoperazone 100 (6.2) 105 (4.5) 105 (3.7) 105 (34.7) 107 (29.3) 121 (35.1) 60 124 
Cefotaxime 101 (3.7) 99 (3.3) 97 (3.1) 103 (17.0) 104 (25.5) 104 (16.5) 9.7 13.2 
Cefquinome 101 (1.8) 101 (1.1) 101 (1.5) 101 (2.6) 103 (5.0) 102 (4.2) 21.0 22.5 
Ceftiofur 102 (8.3) 108 (7.7) 110 (5.3) 94 (18.4) 101 (15.0) 102 (9.6) 126 151 
Cefuroxime 100 (4.9) 95 (4.2) 93 (3.3) 104 (18.9) 108 (21.8) 108 (18.3) 24.9 34.6 
DAC 100 (1.5) 100 (1.4) 100 (1.3) 99 (2.9) 99 (3.4) 100 (2.0) 62 64 
DCCD 101 (2.5) 100 (1.3) 100 (1.5) 101 (2.3) 100 (1.6) 100 (1.7) 102 105 
DCD 104 (17.7) 107 (9.7) 111 (6.4) 107 (25.3) 109 (29.4) 130 (20.8) 124 182 
Biapenem 105 (4.3) 104 (3.5) 103 (3.8) 106 (12.6) 110 (10.2) 110 (11.7) 7.6 9.3 
Doripenem 102 (3.8) 98 (3.3) 98 (2.6) 98 (5.7)  102 (5.4)  102 (2.9) 42.6 45.3 
Ertapenem 97 (4.3) 98 (4.7) 95 (5.7) 98 (9.0) 96 (9.1) 98 (6.4) 21.3 23.9 
Imipenem 100 (4.9) 101 (3.1) 93 (8.7) 99 (21.1) 100 (10.2) 99 (10.6) 23.7 28.3 
Meropenem 101 (2.8) 101 (3.3) 100 (2.1) 98 (4.0) 98 (3.7) 99 (2.1) 10.5 11.0 




















































































































































+ MRM (366.1 -> 113.9) 170801_29.d
Acquisition Time (min)















+ MRM (366.1 -> 208.0) 170801_29.d
Acquisition Time (min)




























+ MRM (364.1 -> 113.9) 170801_29.d
Acquisition Time (min)












+ MRM (364.1 -> 157.9) 170801_29.d
Acquisition Time (min)





















364.1→208.0 364.1→157.9 364.1→113.9 
Acquisition Time (min)












+ MRM (366.1 -> 113.9) 170801_59.d
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+ MRM (366.1 -> 208.0) 170801_59.d
Acquisition Time (min)




























+ MRM (364.1 -> 113.9) 170801_59.d
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+ MRM (364.1 -> 157.9) 170801_59.d
Acquisition Time (min)




















366.1→349.0 366.1→208.0 366.1→113.9 





















+ MRM (366.1 -> 113.9) 170124_03.d
Acquisition Time (min)















+ MRM (366.1 -> 208.0) 170124_03.d
Acquisition Time (min)















+ MRM (364.1 -> 157.9) 170124_03.d
Acquisition Time (min)













+ MRM (364.1 -> 208.0) 170124_03.d Amoxicillin
Acquisition Time (min)















+ MRM (364.1 -> 113.9) 170124_03.d
Acquisition Time (min)




















364.1→208.0 364.1→157.9 364.1→113.9 
+ MRM (366.1 -> 208.0) 170124_62.d
Acquisition Time (min)




























+ MRM (366.1 -> 113.9) 170124_62.d
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+ MRM (364.1 -> 113.9) 170124_62.d
Acquisition Time (min)











+ MRM (364.1 -> 157.9) 170124_62.d
Acquisition Time (min)



















366.1→349.0 366.1→208.0 366.1→113.9 
















B: Injection of cephalexin standard (CSH C18)  D: Injection of cephalexin standard (phenyl-hexyl) 
Acquisition Time (min)












+ MRM (350.1 -> 174.0) 170124_05.d
Acquisition Time (min)















+ MRM (350.1 -> 192.0) 170124_05.d
Acquisition Time (min)






























+ MRM (348.1 -> 106.0) 170124_05.d
Acquisition Time (min)














+ MRM (348.1 -> 174.0) 170124_05.d
Acquisition Time (min)











350.1→106.1 350.1→192.0 350.1→174.0 





















+ MRM (350.1 -> 174.0) 170801_41.d
Acquisition Time (min)















+ MRM (350.1 -> 192.0) 170801_41.d
Acquisition Time (min)


























+ MRM (348.1 -> 106.0) 170801_41.d
Acquisition Time (min)














+ MRM (348.1 -> 174.0) 170801_41.d
Acquisition Time (min)












350.1→106.1 350.1→192.0 350.1→174.0 




















+ MRM (350.1 -> 174.0) 170124_41.d
Acquisition Time (min)













+ MRM (350.1 -> 192.0) 170124_41.d
Acquisition Time (min)






























+ MRM (348.1 -> 106.0) 170124_41.d
Acquisition Time (min)














+ MRM (348.1 -> 174.0) 170124_41.d
Acquisition Time (min)












350.1→106.1 350.1→192.0 350.1→174.0 



























+ MRM (350.1 -> 174.0) 170801_27.d
Acquisition Time (min)













+ MRM (350.1 -> 192.0) 170801_27.d
Acquisition Time (min)



























+ MRM (348.1 -> 106.0) 170801_27.d
Acquisition Time (min)















+ MRM (348.1 -> 174.0) 170801_27.d
Acquisition Time (min)












350.1→106.1 350.1→192.0 350.1→174.0 










































MeCN MeCN:H2O (7:1, v/v)
Online Resource 1  
 
 










Amoxicillin 8 - - 0.02-0.16 
Ampicillin 8 - - 0.02-0.16 
Cloxacillin - - 12 0.15-1.2 
Dicloxacillin - - 12 0.15-1.2 
Mecillinam 4 - - 0.01-0.08 
Methicillin 4 - - 0.01-0.08 
Nafcillin - - 12 0.15-1.2 
Oxacillin - - 12 0.15-1.2 
Penicillin G 8 - - 0.02-0.16 
Penicillin V 8 - - 0.02-0.16 
Piperacillin 8 - - 0.02-0.16 
Ticarcillin - - 4 0.05-0.4 
Cefacetrile - 50 - 0.625-5 
Cefadroxil - - 8 0.1-0.8 
Cephalexin - 40 - 0.5-4 
Cephapirin - 24 - 0.3-2.4 
Cefalonium - - 8 0.1-0.8 
Cefazolin - - 20 0.25-2 
Cefoperazone - - 20 0.25-2 
Cefotaxime 16 - - 0.04-0.32 
Cefquinome - - 8 0.1-0.8 
Ceftiofur - 40 - 0.5-4 
Cefuroxime - - 8 0.1-0.8 
DAC - 24 - 0.3-2.4 
DCCD - 40 - 0.5-4 
DCD - 40 - 0.5-4 
Biapenem 12 - - 0.03-0.24 
Doripenem - - 16 0.2-1.6 
Ertapenem - - 8 0.1-0.8 
Imipenem - - 8 0.1-0.8 
Meropenem - - 4 0.05-0.4 
Faropenem 8 - - 0.02-0.16 




Online Resource 3  
 












Amoxicillin-d4 - 20 - - 0.16 
Ampicillin-d5 10 - - - 0.08 
Nafcillin-d5 - - 37.5 - 0.6 
Penicillin G-d7 10 - - - 0.08 
Penicillin V-d5 10 - - - 0.08 
Piperacillin-d5 10 - - - 0.08 
Cefadroxil-d4 - 50 - - 0.4 
Cefalexin-d5 - - - - 2 
Cefazolin 13C2, 15N - - 62.5 - 1 
Cefquinome-d7 - 50 - - 0.4 
DAC-d6 - - - 37.5 1.2 
DCCD-d3 - - - - 2 
Meropenem-d6 - 25 - - 0.2 
IS = Intermediate Solution; MISS = Mixed Internal Standard Solution. 
 
